tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best Stocks to Buy Now, 8/8/2025, According to Top Analysts

3 Best Stocks to Buy Now, 8/8/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Rhythm Pharmaceuticals (RYTM) – Rhythm Pharmaceuticals is a U.S. biotech company that makes treatments for rare genetic conditions that cause obesity. This week, Needham analyst Joseph Stringer maintained a Buy rating on the stock with a price target of $95 per share. In the last three months, all nine Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 23.95%.

Cigna (CI) – Cigna is a U.S.-based health insurance company that provides medical, dental, and supplemental insurance plans. This week, Deutsche Bank analyst George Hill maintained a Buy rating on the stock and increased the price target to $415 from $372 per share. In the last three months, all 10 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 40.26%.

Wix.com (WIX) – Wix is an Israel-based software company that provides a cloud platform to create, design, and manage websites. This week, Raymond James analyst Josh Beck maintained a Buy rating on the stock with a price target of $250 per share. Interestingly, 15 out of the 16 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 63.91%. 

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Disclaimer & DisclosureReport an Issue

1